title: [The value of lidocaine through different routes of administration in the treatment of tinnitus: a Meta-analysis].
abstract: OBJECTIVE
  To evaluate the clinical value of lidocain in the treatment of tinnitus through three routes of administration (intravenous, intratympanic and acupoint injection) by analyzing literatures.
  
  
  METHODS
  Articles were collected through Hownet, Wanfang, VIP, Pubmed, SciVerse ScienceDirect, Springer and OVID, etc. The articles were strictly evaluated based on their quality. The Meta-analysis was performed to evaluate the outcomes by RevMan 5. 2 software.
  
  
  RESULTS
  A total of 16 articles with 1203 patients were enrolled in the analysis. Their tinnitus history ranged from 7 hours to 20 years. Assessment methods include tinnitus loudness levels, severity scales and subjective feelings. None of articles refer to maintaining time, instead of "short-term", "short" and so on. A total of 133 cases received intravenous injection and the effective rate was 73.4% (98 cases). 50 cases and 332 cases received intratympanic and acupoint injection respectively and their effective rates were 74.0% and 87.7%, respectively. The effective rate ranged from 42.4% to 58.3% in control group. Meta-analysis results indicate that all three routes of lidocaine administrations are more effective than conventional methods (P < 0.05).
  
  
  CONCLUSIONS
  Different routes of lidocaine administration have a good but short time effects on the tinnitus control. It can effectively reduce the time of tinnitus habituation as a complementary treatment. But its value still needs further evaluation.
authors.forename: Hui
authors.initials: H
authors.lastname: Li
authors.forename: Ming
authors.initials: M
authors.lastname: Li
authors.forename: Jianning
authors.initials: J
authors.lastname: Zhang
authors.forename: Xiangcui
authors.initials: X
authors.lastname: Li
authors.forename: Junying
authors.initials: J
authors.lastname: Tan
authors.forename: Bobo
authors.initials: B
authors.lastname: Ji
mesh_terms: D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage* / Q000627:therapeutic use; D014012:Tinnitus / Q000188:drug therapy*
chemical_list: D008012:Lidocaine